AEOLUS PHARMACEUTICALS, INC. 4
4 · AEOLUS PHARMACEUTICALS, INC. · Filed Jul 12, 2007
Insider Transaction Report
Form 4
MCMANUS MICHAEL P
Chief Financial Officer
Transactions
- Award
Non-Qualified Stock Option
2007-07-10+90,000→ 90,000 totalExercise: $1.01Exp: 2017-07-10→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]Options will vest at a rate of 7,500 per month from the grant date for twelve months, provided that Michael McManus is an employee or consultant of Aeolus on the applicable vesting date. In the event of a sale of Aeolus, through a merger or otherwise, all of the options shall be fully vested and immediately exercisable.